(NYSE: STE) Steris's forecast annual revenue growth rate of 7.08% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Steris's revenue in 2024 is $5,407,384,000.On average, 4 Wall Street analysts forecast STE's revenue for 2025 to be $577,055,683,804, with the lowest STE revenue forecast at $575,694,520,471, and the highest STE revenue forecast at $578,239,970,013.
In 2026, STE is forecast to generate $607,266,296,352 in revenue, with the lowest revenue forecast at $604,897,032,235 and the highest revenue forecast at $611,876,267,527.